A safer future isn’t just something we wish for.
We’re creating it.
TO DELIVER NEXT-GEN ARRAYS FOR BETTER HEALTH AND SAFETY.
- Innovation Update: Fast Multiplexed Assay For UTI DetectionMore »
In this innovation update, PathogenDx CEO Milan Patel and Dr. Susan Evans talk D3 Array™-UTI, a fast multiplexed assay for urinary pathogen detection run simultaneously with antibiotic resistance gene markers to support clinicians in administering rapid urinary tract infection treatment and management.
This multiplexed assay delivers unrivaled clinical insight in a single test, with same-shift results.
- DOWNLOAD WHITEPAPER – A New & Novel Approach: UTI Detection + Antibiotic Resistance in a Rapid Affordable Test
Treatment of Urinary Tract Infections is time-consuming, taking anywhere from 2-5 days if antibiotic resistance genes are also tested. When misdiagnosed and further treatment becomes necessary, costs become unmanageable. PathogenDx D3 Array™-UTI is a fast multiplexed platform for urinary pathogen detection run simultaneously with Antibiotic Resistance genes to support clinicians in delivering rapid UTI treatment and management. This test provides:
▪ More flexible, faster and lower cost test than qPCR or NGS technology
▪ Testing for all targets of interest
▪ Each sample analyzed in triplicate for Quality Assurance
▪ 3D cross-linked array architecture enabling rapid binding
▪ Based on our patented technology
Read the more thorough technical breakdown in the whitepaper from Clinical Advisor Dr. Sue Evans here.